Pure Global AI
NCT06307860Recruiting

Comparison of Different Ablation Surgeries on Left Atrial Reverse Remodeling in Patients With Atrial Fibrillation

Comparison of Pulse Field Ablation and Radiofrequency Ablation in Left Atrial Reverse Remodeling in Patients With Paroxysmal Atrial Fibrillation
Yun WanClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Atrial Fibrillation
Drug/Device/Intervention
pulsed field ablation
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Yun Wan
Funder
The Affiliated Ganzhou Hospital of Nanchang University
Location
Ganzhou, China
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2022
End date
Mar 01, 2025
Enrollment
120 participants
Primary outcome

Recurrence rate of atrial arrhythmias,Left atrial end diastolic diameter

Summary

The goal of this Ambispective cohort Study is to compare in patients with paroxysmal atrial
 fibrillation undergo pulse field ablation and radiofrequency ablation, respectively. The main
 question it aims to answer are:Comparison of the therapeutic effects of pulse field ablation
 and traditional thermal ablation on patients with paroxysmal atrial fibrillation and
 postoperative left atrial reverse remodeling.Participants will Perform pulse field ablation
 or radiofrequency ablation according to different groups, and cooperate to complete
 outpatient follow-up 6 months after surgery.

ICD-10 classifications
Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06307860
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06307860 through Pure Global AI's free database. This phase not specified trial is sponsored by Yun Wan and is currently Recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.